_Unit Testing #3: Longevity & Ageing Research
A live discussion at the intersection of cutting edge bio and human health
Welcome to _Unit Testing!
If you’re a long-term subscriber, you have indeed landed in the correct place:
’s Deep Tech Deals is now _Unit Testing.For those of you new to this Substack, welcome! We’re excited to share deal flow, research, conversations and general musings on deep tech investing.
Lastly, my name is Kyle O’Brien. Rand introduced me a while back, but memory span is short these days 😉 We have been co-investing in European deep tech for the past year + and this re-brand represents an (informal) introduction to what’s to come in 2024
Upcoming Panel on Health and Longevity
Our investment thesis is composed of three distinct categories. One of which we call “Frontier Health.” While Rand holds a PhD in Bioinformatics (and is a self-proclaimed bio-hacker), health and longevity has been more of a spectator sport for me. However, like many, I was awakened to the reality of the problems plaguing our healthcare systems exposed during Covid-19. It turns out, many entrepreneurs have been inspired as well, tackling complex biology problems with incredible potential to transform public health. Combined with the advent of modern AI techniques, cheap access to compute resources and a favourable regulatory environment, the barrier to entry has lowered significantly. We are bullish on the predicted outcomes.
To date, we’ve invested in traditional biotech, psychedelics for mental health, and diagnostic hardware. This year, however, proved to be a turning point for the longevity and ageing research ecosystem. What was once viewed as a relatively fringe movement has now begun to merge with mainstream healthcare. The focus has shifted from reactive to preventive care — a renewed emphasis on personalized medicine with the goal of extending healthy lifespan instead of treating the consequences of a poor lifestyle habits.
👇🏼 Join the conversation on June 7th! 👇🏼
This is a diverse and growing ecosystem working to solve problems around all the hallmarks of ageing. As an entry point for a broader audience, we’ve enlisted a couple of experts we’ve met along the way to demystify the field and share their insights from the inside.
Nikolina Lauc, Co-Founder & CEO of Glycanage — perhaps it’s worth taking this opportunity to announce that we are a proud investor in their seed round 🎉
Maximilian Unfried, Core Team at VitaDAO & Longevity Researcher at National University of Singapore
I will be moderating the panel and Rand will serve as co-host and panelist.
Hope to see you there,
Kyle (+Rand)